Phase 1 and pharmacodynamic studies of G3139, a Bcl-2 antisense oligonucleotide, in combination with chemotherapy in refractory or relapsed acute leukemia.

Guido Marcucci; John C Byrd; Guowei Dai; Marko I Klisovic; Peter J Kourlas; Donn C Young; Spero R Cataland; Diane B Fisher; David Lucas; Kenneth K Chan

doi:10.1182/blood-2002-06-1899

Phase 1 and pharmacodynamic studies of G3139, a Bcl-2 antisense oligonucleotide, in combination with chemotherapy in refractory or relapsed acute leukemia.

Identifier:nobleid.org/w1/20260515/5AC4DBB9

Type:Journal Article

0 views

Support unavailableClaim Your Authorship

View Original Paper Source

Embeddable Badge

[![NobleID](https://www.nobleid.org/api/badge/5AC4DBB9.svg?ark=w1%2F20260515%2F5AC4DBB9)](https://nobleid.org/work/w1/20260515/5AC4DBB9)

ARK Inflections

Metadata Policy

Metadata Formats

Bibliometric Analysis

Impact metrics, research fronts, co-authorship networks →

Authors & Claims

Paper Authors

Claim authorship of this work

Phase 1 and pharmacodynamic studies of G3139, a Bcl-2 antisense oligonucleotide, in combination with chemotherapy in refractory or relapsed acute leukemia.

Identifier:nobleid.org/w1/20260515/5AC4DBB9

Type:Journal Article

0 views

Support unavailableClaim Your Authorship

View Original Paper Source

Embeddable Badge

[![NobleID](https://www.nobleid.org/api/badge/5AC4DBB9.svg?ark=w1%2F20260515%2F5AC4DBB9)](https://nobleid.org/work/w1/20260515/5AC4DBB9)

ARK Inflections

Metadata Policy

Metadata Formats

Bibliometric Analysis

Impact metrics, research fronts, co-authorship networks →

Authors & Claims

Paper Authors

Claim authorship of this work